A. ERDEMİR, A. BABAYİĞİT, D. ÖLMEZ, N. UZUNER, Ö. KARAMAN, B. MAKAY, Ö. ANAL

Invasive pulmonary aspergillosis in an immunocompetent infant associated with short term steroid

İnvaziv aspergilloz immunkompetan kişilerde çok nadir görülür. Burada; saptanabilen immün yetmezlik olmamasına rağmen kısa süreli inhale ve sistemik steroid kullanma sonrası invaziv fungal enfeksiyon gelişen bir infantı sunduk. Bu olgu; kısa süreli sistemik ve inhale kortikosteroid tedavisi alan çocuklarda olası fırsatçı fungal enfeksiyon riskini vurgulamak amacı ile sunulmuştur.

İmmunkompetan bir infantta kısa süreli steroid tedavisi ile ilişkili invaziv pulmoner aspergilloz

Invasive aspergillosis occurs very rarely in immunocompetent hosts. We report a case of invasive fungal infection in an infant who was treated with short term of inhaled and systemic steroids although there was no detectable immune deficiency. This case was presented in order to demonstrate the potential risk for opportunistic fungal infections in children treated with short term systemic and inhaled corticosteroids.

PDF

___

1) Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax. 1991;46:15-20.
2) Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781-803.
3) Cornet M, Fleury L, Maslo C, et al. Invasive Aspergillosis Surveillance Network of the Assistance Publique-Hopitaux de Paris. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect. 2002;51:288-96,
4) Karam GH, Griffin FM Jr. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis. 1986;8:357-63.
5) Rello J, Esandi ME, Mariscal D, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998;26:1473-5.
6) Ortuno F, Cabello NJ, Salaveria I, et al. Probable invasive pulmonary aspergillosis and inhaled steroids treatment. Enferm Infecc Microbiol Clin 2002;20:131-2.
7) Roilides E, Uhlig K, Venzon D, et al. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte– induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993;61:4870–7.
8) Staples PJ, Gerding DN, Decker JL, Gordon RS Jr. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974; 17:1–10.
9) Aucott JN. Glucocorticoids and infection. Endocrinol Metab Clin North Am 1994; 23:655–70
10) Zaas AK, Liao G, Chien JW, et al. Plasminogen alleles influence susceptibility to invasive aspergillosis. PLoS Genet. 2008;4:e1000101.
11) Cornet M, Mallat H, Somme D, et al. Fulminant invasive pulmonary aspergillosis in immunocompetent patients: a two-case report. Clin Microbiol Infect 2003;9:1224-1227.
12) Herbrecht R, Natarajan-Ame S, Letscher-Bru V, et al. Invasive pulmonary aspergillosis. Semin Respir Crit Care Med 2004;25:191-202.
13) Wheat L.J. Rapid diagnosis of invasive aspergillosis by antigen detection. Transplant Infectious Disease 2003;5:158-166.
14) Stevens DA, Kan VL, Judson MA. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis. 2000;30:696-709.